• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2021年亚太心脏节律学会(APHRS)心房颤动筛查实践指南。

2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening.

作者信息

Chan Ngai-Yin, Orchard Jessica, Agbayani Michael-Joseph, Boddington Dean, Chao Tze-Fan, Johar Sofian, John Bobby, Joung Boyoung, Krishinan Saravanan, Krittayaphong Rungroj, Kurokawa Sayaka, Lau Chu-Pak, Lim Toon Wei, Linh Pham Tran, Long Vien Hoang, Naik Ajay, Okumura Yasuo, Sasano Tetsuo, Yan Bernard, Raharjo Sunu Budhi, Hanafy Dicky Armein, Yuniadi Yoga, Nwe Nwe, Awan Zahid Aslam, Huang He, Freedman Ben

机构信息

Princess Margaret Hospital Hong Kong Special Administrative Region China.

Agnes Ginges Centre for Molecular Cardiology Centenary Institute Sydney Australia.

出版信息

J Arrhythm. 2021 Dec 28;38(1):31-49. doi: 10.1002/joa3.12669. eCollection 2022 Feb.

DOI:10.1002/joa3.12669
PMID:35222749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8851593/
Abstract

In this paper, the Asia Pacific Heart Rhythm Society (APHRS) sought to provide practice guidance on AF screening based on recent evidence, with specific considerations relevant to the Asia-Pacific region. A key recommendation is opportunistic screening for people aged ≥65 years (all countries), with systematic screening to be considered for people aged ≥75 years or who have additional risk factors (all countries).

摘要

在本文中,亚太心脏节律学会(APHRS)试图根据最新证据提供有关房颤筛查的实践指南,并特别考虑与亚太地区相关的因素。一项关键建议是对65岁及以上人群进行机会性筛查(所有国家),对于75岁及以上人群或有其他风险因素的人群应考虑进行系统性筛查(所有国家)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/49915f4a6916/JOA3-38-31-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/11e23ed10de5/JOA3-38-31-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/9be5f4837ee4/JOA3-38-31-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/8451de256201/JOA3-38-31-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/49915f4a6916/JOA3-38-31-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/11e23ed10de5/JOA3-38-31-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/9be5f4837ee4/JOA3-38-31-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/8451de256201/JOA3-38-31-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/8851593/49915f4a6916/JOA3-38-31-g003.jpg

相似文献

1
2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening.2021年亚太心脏节律学会(APHRS)心房颤动筛查实践指南。
J Arrhythm. 2021 Dec 28;38(1):31-49. doi: 10.1002/joa3.12669. eCollection 2022 Feb.
2
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation.亚太心律学会(APHRS)2017年房颤卒中预防共识指南2021年重点更新。
J Arrhythm. 2021 Nov 13;37(6):1389-1426. doi: 10.1002/joa3.12652. eCollection 2021 Dec.
3
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).心房颤动合并心脏瓣膜病的抗栓治疗:欧洲心律协会(EHRA)和欧洲心脏病学会血栓工作组的联合共识文件,得到 ESC 心脏瓣膜病工作组、南非心脏协会(SA Heart)、心律学会(HRS)、亚太心律学会(APHRS)、南非心脏协会(SA Heart)和拉丁美洲心脏刺激和电生理学会(SOLEACE)的认可。
Europace. 2017 Nov 1;19(11):1757-1758. doi: 10.1093/europace/eux240.
4
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).心房颤动伴瓣膜性心脏病的抗栓治疗:欧洲心律协会(EHRA)和欧洲心脏病学会血栓工作组的联合共识文件的执行摘要,得到 ESC 瓣膜性心脏病工作组、南非心脏协会(SA Heart)、心律学会(HRS)、亚太心律学会(APHRS)、心脏心律失常学会(Cardiac Arrhythmia Society of Southern Africa,CASSA)和拉丁美洲心脏刺激和电生理学会(SOLEACE)的认可。
Thromb Haemost. 2017 Dec;117(12):2215-2236. doi: 10.1160/TH-17-10-0709. Epub 2017 Dec 6.
5
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.2021 年亚太心律学会心房颤动卒中预防聚焦更新共识指南:执行摘要。
Thromb Haemost. 2022 Jan;122(1):20-47. doi: 10.1055/s-0041-1739411. Epub 2021 Nov 13.
6
2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.亚太心脏节律学会2017年心房颤动卒中预防共识
J Arrhythm. 2017 Aug;33(4):345-367. doi: 10.1016/j.joa.2017.05.004. Epub 2017 Jun 27.
7
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).2018 年欧洲共识文件:急性冠状动脉综合征和/或经皮心血管介入治疗的心房颤动患者抗栓治疗管理:欧洲心律协会(EHRA)、欧洲心脏病学会血栓工作组、欧洲经皮心血管介入协会(EAPCI)和欧洲急性心脏护理协会(ACCA)的联合共识文件,得到了心律学会(HRS)、亚太心律学会(APHRS)、拉丁美洲心律学会(LAHRS)和南非心脏心律失常学会(CASSA)的认可。
Europace. 2019 Feb 1;21(2):192-193. doi: 10.1093/europace/euy174.
8
Prognosis and treatment of atrial fibrillation in Asian cities: 1-year review of the Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry.亚洲城市心房颤动的预后与治疗:亚太心律学会心房颤动注册研究的1年回顾
Europace. 2022 Dec 9;24(12):1889-1898. doi: 10.1093/europace/euab327.
9
Clinical utility and prognostic implications of the 4S-AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry.4S-AF方案的临床效用及预后意义:来自亚太心律学会心房颤动注册研究的报告
Eur J Clin Invest. 2022 Oct;52(10):e13825. doi: 10.1111/eci.13825. Epub 2022 Jun 22.
10
Letter responding to Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Societad Latinoamericana de Estimulation Cardiaca y Electrofisiologia (SOLAECE).致《心房颤动筛查:欧洲心律协会(EHRA)共识文件》的信,该文件获心律学会(HRS)、亚太心律学会(APHRS)及拉丁美洲心脏刺激与电生理学会(SOLAECE)认可。
Europace. 2018 May 1;20(5):893. doi: 10.1093/europace/euy008.

引用本文的文献

1
Knowledge, Attitude, and Practice on Atrial Fibrillation and Atrial Fibrillation Screening in High-Risk Population: A Cross-Sectional Study.高危人群对心房颤动及心房颤动筛查的认知、态度和行为:一项横断面研究。
Aging Med (Milton). 2025 Jul 15;8(4):312-323. doi: 10.1002/agm2.70030. eCollection 2025 Aug.
2
A comparative review of current international atrial fibrillation guidelines from a primary care perspective.从初级保健角度对当前国际房颤指南的比较性综述。
Malays Fam Physician. 2025 Jun 7;20:35. doi: 10.51866/cpg.872. eCollection 2025.
3
Epidemiology of Valvular Heart Disease in Asia Pacific Region.

本文引用的文献

1
Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial.植入式循环记录仪检测心房颤动以预防卒中(LOOP研究):一项随机对照试验
Lancet. 2021 Oct 23;398(10310):1507-1516. doi: 10.1016/S0140-6736(21)01698-6. Epub 2021 Aug 29.
2
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial.系统筛查心房颤动(STROKESTOP)的临床结局:一项多中心、平行组、非盲、随机对照试验。
Lancet. 2021 Oct 23;398(10310):1498-1506. doi: 10.1016/S0140-6736(21)01637-8. Epub 2021 Aug 29.
3
亚太地区心脏瓣膜病流行病学
JACC Asia. 2025 May 3;5(6):718-43. doi: 10.1016/j.jacasi.2025.03.011.
4
Addressing Cardiovascular Diseases Challenges in South Korea: Strategies to Improve Outcomes.应对韩国心血管疾病挑战:改善治疗效果的策略
Korean Circ J. 2025 Jul;55(7):557-583. doi: 10.4070/kcj.2024.0385. Epub 2025 Apr 7.
5
Current Status of Tricuspid Valve Interventions in Asia Pacific Region.亚太地区三尖瓣介入治疗的现状
JACC Asia. 2025 Mar;5(3 Pt 2):405-423. doi: 10.1016/j.jacasi.2024.10.008. Epub 2024 Dec 17.
6
Serum Vasoactive Intestinal Peptide as a Novel Biomarker for Low-Voltage Areas in Patients With Atrial Fibrillation.血清血管活性肠肽作为心房颤动患者低电压区域的新型生物标志物。
J Am Heart Assoc. 2025 Apr;14(7):e039192. doi: 10.1161/JAHA.124.039192. Epub 2025 Mar 21.
7
The burden of atrial fibrillation and unmet needs of its management in Southeast Asia and South Asia.东南亚和南亚地区心房颤动的负担及其管理方面未满足的需求。
Lancet Reg Health Southeast Asia. 2025 Feb 21;34:100549. doi: 10.1016/j.lansea.2025.100549. eCollection 2025 Mar.
8
Atrial Fibrillation Screening in the Elderly: A Cost-Effectiveness Analysis for Public Health Policy.老年人房颤筛查:一项针对公共卫生政策的成本效益分析
JACC Asia. 2024 Nov 26;5(1):160-171. doi: 10.1016/j.jacasi.2024.09.016. eCollection 2025 Jan.
9
High-density mapping in catheter ablation for atrial fibrillation in Asia Pacific region: An observational study.亚太地区心房颤动导管消融中的高密度标测:一项观察性研究。
J Arrhythm. 2024 Dec 18;41(1):e13168. doi: 10.1002/joa3.13168. eCollection 2025 Feb.
10
Implementing a remote self-screening programme for atrial fibrillation using digital health technology among community-dwellers aged 75 years and older: a qualitative evaluation.利用数字健康技术在 75 岁及以上社区居民中实施远程自我筛查心房颤动方案:定性评估。
BMJ Open. 2024 Oct 16;14(10):e088260. doi: 10.1136/bmjopen-2024-088260.
High-intensity atrial fibrillation screening to prevent stroke.
高强度心房颤动筛查以预防中风。
Lancet. 2021 Oct 23;398(10310):1465-1467. doi: 10.1016/S0140-6736(21)01785-2. Epub 2021 Aug 29.
4
Population screening for atrial fibrillation to prevent stroke.进行房颤人群筛查以预防中风。
Lancet. 2021 Oct 23;398(10310):1463-1465. doi: 10.1016/S0140-6736(21)01750-5. Epub 2021 Aug 29.
5
Atrial Fibrillation Detected by Single Time-Point Handheld Electrocardiogram Screening and the Risk of Ischemic Stroke.单点手持式心电图筛查发现的心房颤动与缺血性脑卒中风险。
Thromb Haemost. 2022 Feb;122(2):286-294. doi: 10.1055/a-1588-8867. Epub 2021 Sep 29.
6
World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update.世界心脏联盟心房颤动路线图-2020 年更新版。
Glob Heart. 2021 May 27;16(1):41. doi: 10.5334/gh.1023.
7
Validation of Adhesive Single-Lead ECG Device Compared with Holter Monitoring among Non-Atrial Fibrillation Patients.非房颤患者中粘贴式单导联心电图设备与动态心电图监测的验证比较。
Sensors (Basel). 2021 Apr 30;21(9):3122. doi: 10.3390/s21093122.
8
Comparison between a 6‑lead smartphone ECG and 12‑lead ECG in athletes.6 导联智能手机心电图与 12 导联心电图在运动员中的比较。
J Electrocardiol. 2021 May-Jun;66:95-97. doi: 10.1016/j.jelectrocard.2021.03.008. Epub 2021 Apr 9.
9
Atrial fibrillation prevalence and risk profile from novel community-based screening in Thailand: A prospective multi-centre study.泰国基于社区的新型筛查中房颤的患病率和风险概况:一项前瞻性多中心研究。
Int J Cardiol Heart Vasc. 2021 Jan 12;32:100709. doi: 10.1016/j.ijcha.2020.100709. eCollection 2021 Feb.
10
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation.2020 年加拿大心血管学会/加拿大心律学会心房颤动管理综合指南。
Can J Cardiol. 2020 Dec;36(12):1847-1948. doi: 10.1016/j.cjca.2020.09.001. Epub 2020 Oct 22.